Inovio Pharmaceuticals Stock In The News
| INO Stock | USD 2.03 0.10 5.18% |
Our overall analysis of Inovio Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Inovio Pharmaceuticals. The specific impact of Inovio Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Inovio Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Inovio Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Inovio Pharmaceuticals Backtesting and Inovio Pharmaceuticals Hype Analysis. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
Inovio |
Inovio Pharmaceuticals Today Top News and Investor Outlook
Inovio Pharmaceuticals Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Inovio and other traded companies coverage with news coverage. We help investors stay connected with Inovio headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Inovio Stock performance. Please note that trading solely based on the Inovio Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Inovio Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Inovio earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Inovio Pharmaceuticals that are available to investors today. That information is available publicly through Inovio media outlets and privately through word of mouth or via Inovio internal channels. However, regardless of the origin, that massive amount of Inovio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inovio Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inovio Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inovio Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inovio Pharmaceuticals alpha.
Inovio Largest EPS Surprises
Earnings surprises can significantly impact Inovio Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-10 | 2023-03-31 | -0.14 | -0.16 | -0.02 | 14 | ||
2015-03-16 | 2014-12-31 | -0.1 | -0.12 | -0.02 | 20 | ||
2014-11-10 | 2014-09-30 | -0.14 | -0.12 | 0.02 | 14 | ||
2019-08-08 | 2019-06-30 | -0.27 | -0.3 | -0.03 | 11 | ||
2018-11-08 | 2018-09-30 | -0.3 | -0.27 | 0.03 | 10 | ||
2016-05-09 | 2016-03-31 | -0.14 | -0.11 | 0.03 | 21 |
Inovio Pharmaceuticals Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Inovio Pharmaceuticals Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
12th of March 2025
INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025 at finance.yahoo.com
4th of March 2025
BALVERSA Adoption on the Rise Meeting Unmet Needs in Advanced Urothelial Cancer DelveInsig... at finance.yahoo.com
27th of February 2025
Acquisition by Peter Kies of 31900 shares of Inovio Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider
19th of February 2025
Inovio Investor Alert Class Action Lawsuit Filed - ACCESS Newswire at news.google.com
12th of February 2025
Clinical and Immunological Results from Phase 12 Study of INO-3107 as a Treatment for Recu... at finance.yahoo.com
5th of February 2025
BlackRock, Inc. Expands Stake in Inovio Pharmaceuticals Inc. - GuruFocus.com at news.google.com
30th of January 2025
Vaccines Market to Grow by USD 193.7 Billion , Increased Funding for Development and New L... at finance.yahoo.com
29th of January 2025
INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference -... at news.google.com
10th of January 2025
Inovio Pharmaceuticals SWOT analysis dna-based immunotherapy firm faces hurdles at investing.com
13th of December 2024
INOVIO Announces Pricing of 30 Million Public Offering at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Inovio Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Inovio Pharmaceuticals' short interest history, or implied volatility extrapolated from Inovio Pharmaceuticals options trading.
Check out Inovio Pharmaceuticals Backtesting and Inovio Pharmaceuticals Hype Analysis. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Revenue Per Share | Quarterly Revenue Growth (0.55) | Return On Assets | Return On Equity |
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.